Dermata Therapeutics Inc
Change company Symbol lookup
Select an option...
DRMA Dermata Therapeutics Inc
GTIM Good Times Restaurants Inc
AMPS Altus Power Inc
ELEV Elevation Oncology Inc
BMR Beamr Imaging Ltd
JEMTF iPath? GEMS Index ETN
IBRX Immunitybio Inc
PRVA Privia Health Group Inc
CNSP CNS Pharmaceuticals Inc
SMTC Semtech Corp
Go

Health Care : Biotechnology |
Company profile

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company. The Company is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its product candidates include DMT310 and DMT410. Its lead product candidate DMT310 is intended to utilize its Spongilla technology for the once-weekly treatment of a variety of skin diseases with its initial focus being on the treatment of acne vulgaris. DMT310 completed a Phase Ib proof of concept (POC) trial in psoriasis. Its second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of its sponge powder followed by one topical application of botulinum toxin for delivery into the dermis. DMT410 Phase I POC trial of DMT410 for the treatment of multiple aesthetic skin conditions, including reduction of pore size, sebum production, and fine lines.

Closing Price
$1.91
Day's Change
-0.02 (-1.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.09
Day's Low
1.83
Volume
(Average)
Volume:
494,292

10-day average volume:
465,601
494,292
  • Prev Close
    1.93
  • Today's Open
    1.96
  • Day's Range
    1.83-2.09
  • Avg Vol (10-day)
    465.6K
  • Last (time)
    3:59p ET 06/08/23
  • Last (size)
    150
  • 52-Wk Range
    0.98 - 16.64
    LowHigh
  • (06/30/22 - 04/06/23)
    94.90%
  • 180.2%
  • Market Cap
    5.4M
  • Shares Outstanding
    2.8M
  • -11.50
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 4.98
  • (% of float 05/15/23)
    3.33

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.